BeyondSpring | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Xiangmin Cui(12.3%),Decheng Capital China Life Sciences USD Fund III, L.P.(4.9%), etc.
BeyondSpring | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BeyondSpring | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BeyondSpring | EFFECT: Others
BeyondSpring | CORRESP: CORRESP
BeyondSpring | F-3/A: Registration statement for specified transactions by certain foreign private issuers (Amendment)
BeyondSpring | CORRESP: CORRESP
BeyondSpring | UPLOAD: Others
BeyondSpring | F-3: Registration statement for specified transactions by certain foreign private issuers
BeyondSpring | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BeyondSpring | 424B5: Prospectus
BeyondSpring | 20-F: FY2023 Annual Report
BeyondSpring | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BeyondSpring | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BeyondSpring | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lan Huang(26.17%),Linqing Jia(26.17%), etc.
BeyondSpring | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BeyondSpring | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BeyondSpring | 6-K: Report of foreign private issuer (related to financial reporting)
BeyondSpring | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
BeyondSpring | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data
No Data